Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) | MicrobiomeTrials← Back to trialsNCT07721012
Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-07-31Est. Completion: 2027-08-31
Enrollment target: 120 participants Locations- Beijing Traditional Chinese Medicine Hospital, Capital Medical University, Beijing, China
- The First Hospital of Hunan University of Chinese Medicine, Changsha, China
- Daqing People's Hospital, Daqing, China
- GuangDong Second Traditional Chinese Medicine Hospital, Guangzhou, China
- Inner Mongolia Hospital of Traditional Chinese Medicine, Hohhot, China
- Lianyungang Hospital of Traditional Chinese Medicine, Lianyungang, China
- Luoyang First People's Hospital, Luoyang, China
- Luoyang Third People's Hospital, Luoyang, China
- Meihekou Central Hospital, Meihekou, China
- The Third Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China
- Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China
- The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China
- Wenzhou TCM Hospital of Zhejiang Chinese Medical University, Wenzhou, China
- Xiamen Hospital of Traditional Chinese Medicine, Xiamen, China
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of li…
Istanbul, Turkey (Türkiye)Completed Nov 25, 2021
Functional DyspepsiaIrritable Bowel Syndrome With Diarrhea
1. To conduct a multicenter, randomized controlled trial across four hospitals to evaluate the efficacy of Hewei Anchang…
Beijing, ChinaEst. completion Jun 30, 2028